Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial.

Saved in:
Bibliographic Details
Title: Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial.
Authors: Ureshino H; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan. sr0795@cc.saga-u.ac.jp., Murai K; Department of Hematology, Iwate Prefectural Central Hospital, Morioka, Japan., Kumagai T; Department of Hematology, Ome Medical Center, Ome, Japan., Mino T; Department of Hematology, Hiroshima City Asa Hospital, Hiroshima, Japan., Nishiwaki K; Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, Kashiwa, Japan., Wakita S; Department of Hematology, Nippon Medical School, Tokyo, Japan., Takeoka T; Division of Hematology and Immunology, Japanese Red Cross Otsu Hospital, Otsu, Japan., Mita M; Department of Hematology, Shirakawa Kosei General Hospital, Shirakawa, Japan., Yoshida C; Department of Hematology, National Hospital Organization Mito Medical Center, Ibaraki, Japan., Uoshima N; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan., Fukushima T; Department of Hematology and Immunology, Kanazawa Medical University, Kanazawa, Japan., Kuroda J; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan., Kondo T; Blood Disorders Center, Aiiku Hospital, Sapporo, Japan., Chiba M; Department of Hematology, Asahikawa City Hospital, Asahikawa, Japan., Miyazaki T; Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan., Io K; Department of Hematology, Kansai Electric Power Hospital, Osaka, Japan., Ueda T; Department of Hematology and Oncology, The University of Osaka, Suita, Japan., Ono T; Divison of Hematology, Hamamatsu University School of Medicine, Hamamatsu, Japan., Usuki K; Forth Department of Internal Medicine, Mizonokuchi Hospital, Teikyo University School of Medicine, Itabashi City, Japan., Yamauchi T; Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan., Fujimaki K; Department of Hematology, Fujisawa City Hospital, Fujisawa, Japan., Ikezoe T; Department of Hematology, Fukushima Medical University, Fukushima, Japan., Kawaguchi A; Education and Research Center for Community Medicine, Faculty of Medicine, Saga University, Saga, Japan., Kimura S; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.
Source: Blood cancer journal [Blood Cancer J] 2026 May 28; Vol. 16 (1). Date of Electronic Publication: 2026 May 28.
Publication Type: Letter
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42209454
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ureshino+H%22">Ureshino H</searchLink>; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan. sr0795@cc.saga-u.ac.jp.<br /><searchLink fieldCode="AU" term="%22Murai+K%22">Murai K</searchLink>; Department of Hematology, Iwate Prefectural Central Hospital, Morioka, Japan.<br /><searchLink fieldCode="AU" term="%22Kumagai+T%22">Kumagai T</searchLink>; Department of Hematology, Ome Medical Center, Ome, Japan.<br /><searchLink fieldCode="AU" term="%22Mino+T%22">Mino T</searchLink>; Department of Hematology, Hiroshima City Asa Hospital, Hiroshima, Japan.<br /><searchLink fieldCode="AU" term="%22Nishiwaki+K%22">Nishiwaki K</searchLink>; Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, Kashiwa, Japan.<br /><searchLink fieldCode="AU" term="%22Wakita+S%22">Wakita S</searchLink>; Department of Hematology, Nippon Medical School, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Takeoka+T%22">Takeoka T</searchLink>; Division of Hematology and Immunology, Japanese Red Cross Otsu Hospital, Otsu, Japan.<br /><searchLink fieldCode="AU" term="%22Mita+M%22">Mita M</searchLink>; Department of Hematology, Shirakawa Kosei General Hospital, Shirakawa, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshida+C%22">Yoshida C</searchLink>; Department of Hematology, National Hospital Organization Mito Medical Center, Ibaraki, Japan.<br /><searchLink fieldCode="AU" term="%22Uoshima+N%22">Uoshima N</searchLink>; Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.<br /><searchLink fieldCode="AU" term="%22Fukushima+T%22">Fukushima T</searchLink>; Department of Hematology and Immunology, Kanazawa Medical University, Kanazawa, Japan.<br /><searchLink fieldCode="AU" term="%22Kuroda+J%22">Kuroda J</searchLink>; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.<br /><searchLink fieldCode="AU" term="%22Kondo+T%22">Kondo T</searchLink>; Blood Disorders Center, Aiiku Hospital, Sapporo, Japan.<br /><searchLink fieldCode="AU" term="%22Chiba+M%22">Chiba M</searchLink>; Department of Hematology, Asahikawa City Hospital, Asahikawa, Japan.<br /><searchLink fieldCode="AU" term="%22Miyazaki+T%22">Miyazaki T</searchLink>; Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Io+K%22">Io K</searchLink>; Department of Hematology, Kansai Electric Power Hospital, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Ueda+T%22">Ueda T</searchLink>; Department of Hematology and Oncology, The University of Osaka, Suita, Japan.<br /><searchLink fieldCode="AU" term="%22Ono+T%22">Ono T</searchLink>; Divison of Hematology, Hamamatsu University School of Medicine, Hamamatsu, Japan.<br /><searchLink fieldCode="AU" term="%22Usuki+K%22">Usuki K</searchLink>; Forth Department of Internal Medicine, Mizonokuchi Hospital, Teikyo University School of Medicine, Itabashi City, Japan.<br /><searchLink fieldCode="AU" term="%22Yamauchi+T%22">Yamauchi T</searchLink>; Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.<br /><searchLink fieldCode="AU" term="%22Fujimaki+K%22">Fujimaki K</searchLink>; Department of Hematology, Fujisawa City Hospital, Fujisawa, Japan.<br /><searchLink fieldCode="AU" term="%22Ikezoe+T%22">Ikezoe T</searchLink>; Department of Hematology, Fukushima Medical University, Fukushima, Japan.<br /><searchLink fieldCode="AU" term="%22Kawaguchi+A%22">Kawaguchi A</searchLink>; Education and Research Center for Community Medicine, Faculty of Medicine, Saga University, Saga, Japan.<br /><searchLink fieldCode="AU" term="%22Kimura+S%22">Kimura S</searchLink>; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2026 May 28; Vol. 16 (1). <i>Date of Electronic Publication: </i>2026 May 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42209454
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41408-026-01526-7
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ureshino H
      – PersonEntity:
          Name:
            NameFull: Murai K
      – PersonEntity:
          Name:
            NameFull: Kumagai T
      – PersonEntity:
          Name:
            NameFull: Mino T
      – PersonEntity:
          Name:
            NameFull: Nishiwaki K
      – PersonEntity:
          Name:
            NameFull: Wakita S
      – PersonEntity:
          Name:
            NameFull: Takeoka T
      – PersonEntity:
          Name:
            NameFull: Mita M
      – PersonEntity:
          Name:
            NameFull: Yoshida C
      – PersonEntity:
          Name:
            NameFull: Uoshima N
      – PersonEntity:
          Name:
            NameFull: Fukushima T
      – PersonEntity:
          Name:
            NameFull: Kuroda J
      – PersonEntity:
          Name:
            NameFull: Kondo T
      – PersonEntity:
          Name:
            NameFull: Chiba M
      – PersonEntity:
          Name:
            NameFull: Miyazaki T
      – PersonEntity:
          Name:
            NameFull: Io K
      – PersonEntity:
          Name:
            NameFull: Ueda T
      – PersonEntity:
          Name:
            NameFull: Ono T
      – PersonEntity:
          Name:
            NameFull: Usuki K
      – PersonEntity:
          Name:
            NameFull: Yamauchi T
      – PersonEntity:
          Name:
            NameFull: Fujimaki K
      – PersonEntity:
          Name:
            NameFull: Ikezoe T
      – PersonEntity:
          Name:
            NameFull: Kawaguchi A
      – PersonEntity:
          Name:
            NameFull: Kimura S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 05
              Text: 2026 May 28
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2044-5385
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood cancer journal
              Type: main
ResultId 1